Ran Wei

3.7k citations
98 papers · 2.7k · 3 hit papers · h-index 24

Impact in

Papers in

Ran Wei

95 papers receiving 2.7k citations

Ran Wei's Hit Papers

Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes 2024 · 150 citations
1500+1+3Years since publication100200300400

Peers

Ran Wei
Comparison fields: 5 of 107
  • Biological Psychiatry 94
  • Cancer Research 562
  • Pulmonary and Respiratory Medicine 600
  • Oncology 262
  • Microbiology 68
Replace David E. Szymkowski with:
David E. Szymkowski United States
Zhihua Yang China
Alessandra Carè Italy
Angelos D. Gritzapis Greece
Masato Mitsuhashi United States
Cecilia L. Speyer United States
Εkaterini Chatzaki Greece
Hua Zhu China
Nicholas Jason Roberts United States
Jiabei Wang China
Ran Wei relative to David E. Szymkowski United States David E. Szymkowski's profile →
Citations per field
00.5×2×4×6.8×
David E. Szymkowski · 1×
Citations per year

Countries citing papers authored by Ran Wei

Since Specialization
Citations

This map shows the geographic impact of Ran Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Wei more than expected).

Fields of papers citing papers by Ran Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Wei. The network helps show where Ran Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Ran Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ran Wei Line = papers co-authored together Ran Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
Hit paper breakdown →
2022404
2
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Hit paper breakdown →
2021275
3
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes
Hit paper breakdown →
2024150
4 2009131
5 2017127
6 2013122
7 201385
8 201385
9 202073
10 202061
11 201957
12 201053
13 201751
14 202141
15 201939
16 201837
17 202236
18 202132
19 201531
20 202029

About Ran Wei

Ran Wei is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pediatrics, Perinatology and Child Health, Biological Psychiatry and Cancer Research, having authored 98 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (19 papers), Gastric Cancer Management and Outcomes (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Plant Stress Responses and Tolerance (3 papers), Prenatal Screening and Diagnostics (3 papers), Tryptophan and brain disorders (3 papers) and Bone and Dental Protein Studies (3 papers). The work is most often cited by research in Biological Psychiatry (94 citations), Cancer Research (562 citations), Pulmonary and Respiratory Medicine (600 citations), Oncology (262 citations) and Microbiology (68 citations). Ran Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hang Fai Kwok, Yao Lin, Libin Guo, Siew Eng Chua, Grainne Mary McAlonan, Chris Shaw, Edward X. Wu, Courtney Voss, Qi Li and Edward Sai Kam Hui. Their work appears in journals such as Annals of Oncology, ESMO Open, Scientific Reports, The Oncologist and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact